Common Contracts

10 similar Tender Agreement contracts by Valeant Pharmaceuticals International, Inc.

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and JOHN GLENN
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and John Glenn (“Company Stockholder”).

AutoNDA by SimpleDocs
TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and INLIGN CP III, LLC
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Inlign CP III, LLC, a Delaware limited liability company (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and DAVID HOLTHE
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and David Holthe (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and JEFF NARDOCI
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Jeff Nardoci (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and ERIC STANG
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Eric Stang (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and HAROLD L. COVERT
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Harold L. Covert (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and CATHY L. MCCARTHY
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Cathy L. McCarthy (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and LINDA GRAEBNER
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Linda Graebner (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and MARK M. SIECZKAREK
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and Mark M. Sieczkarek (“Company Stockholder”).

TENDER AGREEMENT Dated as of December 15, 2013 among VALEANT PHARMACEUTICALS INTERNATIONAL, SAPPHIRE SUBSIDIARY CORP. and H. DANIEL FERRARI
Tender Agreement • December 23rd, 2013 • Valeant Pharmaceuticals International, Inc. • Pharmaceutical preparations • Delaware

This TENDER AGREEMENT, dated as of December 15, 2013 (this “Agreement”), is among Valeant Pharmaceuticals International, a Delaware corporation (“Parent”), Sapphire Subsidiary Corp., a Delaware corporation and a wholly owned Subsidiary of Parent (“Merger Sub”), and H. Daniel Ferrari (“Company Stockholder”).

Time is Money Join Law Insider Premium to draft better contracts faster.